Loading viewer...
investor_presentation
Format: PDF investor_presentation
Ginkgo Bioworks presents its Q2 2022 business update and financial review as of August 15, 2022. The presentation covers company operations, strategic initiatives, and anticipated results in synthetic biology and biosecurity sectors, with discussion of pending merger activities including the proposed Zymergen acquisition.
investor_presentation
22 Pages
WSP Global